Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
10
×
national blog main
biotech
boston blog main
clinical trials
fda
national top stories
san francisco blog main
national
new york blog main
new york top stories
san francisco top stories
sanofi
startups
amgen
cancer
gilead sciences
indiana blog main
indiana top stories
new york
san diego blog main
seattle blog main
seattle top stories
tech
vc
abbvie
akili interactive labs
akouos
alex azar
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
artificial intelligence
astrazeneca
avapritinib
biogen
blood draw
What
announced
10
×
drug
medicine
medicines
plans
based
ceo
week
approval
blood
blueprint
cancer
fda
firm
lowering
medical
new
sciences
technologies
year
aces
acquisitions
adding
adds
administration
alex
approved
area
backs
banks
bay
bets
big
bio
biopharma
biopsy
bodily
buildout
california
capital
Language
unset
Current search:
announced
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Magnolia Medical Captures $20M to Reduce Blood Culture Contamination
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@venturebeat.com
6 years ago
Menlo Ventures banks on tech-driven life sciences, adds Greg Yap as new partner